Background
Alzheimer’s disease is a progressive neurological disorder that affects millions of people worldwide. It is a fatal, degenerative disease characterized by memory loss, confusion, and other symptoms (Bhujbal et al., 2022). Much research has recently been conducted to understand better the mechanisms underlying this crippling illness (Rayathala et al., 2022).
Although the physiological aspects of Alzheimer’s disease have been extensively studied, more research is required to understand how the illness affects the senses and perceptions of those affected (Gutierrez & Limon, 2022). The work will examine how various sensory and perceptual abilities, such as vision, hearing, touch, taste, and smell, are affected in people with Alzheimer’s disease and how to address these changes to improve daily functioning. Changes in sensory perception in Alzheimer’s patients are predicted to impact their daily activities. Additional research into the sensory and perceptual changes associated with the illness can provide insight into the best ways to support and care for those affected by Alzheimer’s, ultimately improving their quality of life.
Annotated Bibliography
Bhujbal, S. S., Kad, M. M., & Patole, V. C. (2022). Recent diagnostic techniques for the detection of Alzheimer’s disease: a short review. Irish Journal of Medical Science (1971 -). Web.
The source is a review article that discusses current methods for diagnosing Alzheimer’s disease. The authors review some methods, including cerebrospinal fluid analysis, positron emission tomography, single-photon emission computed tomography, magnetic resonance imaging, and neuropsychological testing. The review also discusses the significance of early diagnosis of Alzheimer’s disease and the need for additional research in this field. The article will help readers learn more about the current diagnostic approaches for Alzheimer’s disease and shed more light on the significance of early detection.
Gutierrez, B. A., & Limon, A. (2022). Synaptic disruption by soluble oligomers in patients with Alzheimer’s and Parkinson’s disease. Biomedicines, 10(7), 1743. Web.
The study looks at how soluble oligomers affect synaptic disruption in people with Parkinson’s and Alzheimer’s diseases. In addition to discussing the effects of soluble oligomers on synaptic disruption, the authors also discuss the role of the prion protein in Alzheimer’s and Parkinson’s diseases. This study will clarify how soluble oligomers contribute to the onset of Alzheimer’s and Parkinson’s diseases and may provide insight into potential treatments.
Rayathala, J., C, K. K., & P, V. (2022). Review on Alzheimer’s disease: past, present and future. Journal of Innovations in Applied Pharmaceutical Science (JIAPS), 28–31. Web.
The source offers a review article examining Alzheimer’s disease’s past, present, and future. The authors review the background of Alzheimer’s disease, its current state, and potential future treatments and preventative measures. This information will be used to better understand the history and current status of Alzheimer’s disease and shed light on possible treatments and preventative measures that could be developed in the future.